BANK VONTOBEL/CALL/CVS HEALTH/65/0.1/19.07.24 Share Price

Warrant

DE000VD49DU4

Real-time Bid/Ask 18:26:16 17/06/2024 BST
0.047 EUR / 0.057 EUR -18.75% Intraday chart for BANK VONTOBEL/CALL/CVS HEALTH/65/0.1/19.07.24
Current month+255.56%
1 month+146.15%
Date Price Change
17/06/24 0.045 -29.69%
14/06/24 0.064 +68.42%
13/06/24 0.038 -15.56%
12/06/24 0.045 -11.76%
11/06/24 0.051 -37.80%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 07:17 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Vontobel Vontobel
WKN VD49DU
ISINDE000VD49DU4
Date issued 29/04/2024
Strike 65 $
Maturity 19/07/2024 (32 Days)
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.54
Lowest since issue 0.01
Spread 0.01
Spread %16.95%

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
60.22 USD
Average target price
69.02 USD
Spread / Average Target
+14.61%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW